High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.

Abstract:

:CXCL16 is a new member of the chemokine superfamily, which exists in a transmembrane as well as a soluble form. Its receptor CXCR6 is detected on CD4(+) T cells, CD8(+) T cells, and natural killer T cells. Here, we report a significant correlation of CXCL16 expression by tumor cells with the infiltration of T cells and prognosis in colorectal cancer (CRC). We first found that CXCL16 expression was consistently up-regulated more in tumor tissues than in normal mucosa derived from the same CRC patients. Four human CRC cell lines also expressed CXCL16 mRNA and secreted soluble CXCL16. We next examined the expression of CXCL16 and infiltration of lymphocytes in CRC specimens (n = 58) by immunohistochemistry. CRC patients with high levels of CXCL16 expression (n = 43) had higher levels of CD4(+) and CD8(+) tumor-infiltrating lymphocytes (TIL; P < 0.01) than those with low levels of CXCL16 expression (n = 15). Furthermore, the high CXCL16 expression group showed significantly better prognosis than the low CXCL16 expression group (P < 0.05). Collectively, our data suggest that the expression of CXCL16 by tumor cells enhances the recruitment of TILs, thereby bringing about a better prognosis in CRC. Thus, CXCL16 is a new prognostic biomarker and may be useful for the development of a more effective therapeutic strategy for CRC.

journal_name

Cancer Res

journal_title

Cancer research

authors

Hojo S,Koizumi K,Tsuneyama K,Arita Y,Cui Z,Shinohara K,Minami T,Hashimoto I,Nakayama T,Sakurai H,Takano Y,Yoshie O,Tsukada K,Saiki I

doi

10.1158/0008-5472.CAN-06-3424

subject

Has Abstract

pub_date

2007-05-15 00:00:00

pages

4725-31

issue

10

eissn

0008-5472

issn

1538-7445

pii

67/10/4725

journal_volume

67

pub_type

杂志文章
  • Heterogeneity in cell-associated transformation-sensitive proteins antigenically related to fibronectin.

    abstract::Antiserum to purified fibronectin has been used to investigate transformation-associated heterogeneity in surface components antigenically related to fibronectin. Examination of extracts from surface-labeled rat cells by gradient gel electrophoresis revealed in "normal" cells the presence of two species with approxima...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rieber M,Rieber MS

    更新日期:1979-05-01 00:00:00

  • Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.

    abstract::Increased activity, membrane association, and secretion of cathepsin B have been shown to correlate positively with invasiveness and the metastatic properties of many tumor entities. Cathepsin B is able to directly facilitate invasion by degrading extracellular matrix components or to indirectly facilitate invasion by...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Krueger S,Haeckel C,Buehling F,Roessner A

    更新日期:1999-12-01 00:00:00

  • Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis.

    abstract::In previous studies, we reported that key antioxidant and DNA repair genes are regulated differently in normal bronchial epithelial cells of lung cancer cases compared with non-lung cancer controls. In an effort to develop a biomarker for lung cancer risk, we evaluated the transcript expressions of 14 antioxidant, DNA...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1568

    authors: Blomquist T,Crawford EL,Mullins D,Yoon Y,Hernandez DA,Khuder S,Ruppel PL,Peters E,Oldfield DJ,Austermiller B,Anders JC,Willey JC

    更新日期:2009-11-15 00:00:00

  • A monoclonal antibody, CSTO-1, against a stomach adenocarcinoma-associated antigen.

    abstract::A monoclonal antibody, CSTO-1, has been produced against a stomach adenocarcinoma-associated antigen. The antibody is cytotoxic to stomach, colon, and lung adenocarcinoma lines but is completely noncytotoxic to normal blood elements and leukemic cell lines. The monoclonal antibody reacts with tumor cell membranes in e...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Togashi H,Terasaki PI,Chia D,Kukes G,Mugishima H,Kasai K,Suyama N,Fukushima K,Hirota M

    更新日期:1984-09-01 00:00:00

  • Phase I-II study of epirubicin in multiple myeloma.

    abstract::Forty patients with relapsed (26) or refractory (14) myeloma were treated with epirubicin of doses of 75, 90, 105, and 120 mg/m2 in groups of 6 or more patients to test for response, maximum tolerated dose, and toxicity. Thirteen patients had received prior doxorubicin and were included in the dose findings part of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Case DC Jr,Ervin TJ,Gams R,Sonneborn HL,Paul SD,Oldham FB

    更新日期:1988-11-01 00:00:00

  • Immunotherapy of murine hepatic metastases with lymphokine-activated killer cells expanded in serum-free media and recombinant interleukin 2.

    abstract::It has been shown that the systemic administration of lymphokine-activated killer (LAK) cells with recombinant interleukin 2 (RIL-2) is effective in reducing the number of established pulmonary and hepatic metastases in murine models. Similarly, this modality of therapy has been proven effective against certain select...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lafreniere R,Borkenhagen K,Bryant LD,Huchcroft S

    更新日期:1989-05-01 00:00:00

  • Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

    abstract::A widely held tenet of present day oncology is that tumor cells treated with anticancer agents die from apoptosis, and that cells resistant to apoptosis are resistant to cancer treatment. We suggest, in this review, that this tenet may need to be reexamined for human tumors of nonhematological origin, for two principa...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Brown JM,Wouters BG

    更新日期:1999-04-01 00:00:00

  • Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.

    abstract::Targeting the tyrosine kinase activity of Bcr-Abl is an attractive therapeutic strategy in chronic myeloid leukemia (CML) and in Bcr-Abl-positive acute lymphoblastic leukemia. Whereas imatinib, a selective inhibitor of Bcr-Abl tyrosine kinase, is now used in frontline therapy for CML, second-generation inhibitors of B...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1008

    authors: Mahon FX,Hayette S,Lagarde V,Belloc F,Turcq B,Nicolini F,Belanger C,Manley PW,Leroy C,Etienne G,Roche S,Pasquet JM

    更新日期:2008-12-01 00:00:00

  • Biological behavior of malignant melanoma cells correlated to their survival in vivo.

    abstract::Successive B16 melanoma tumor lines were selected for their ability to form pulmonary tumor nodules. This was accomplished by injecting tumor cells i.v. into syngeneic C57BL/6 mice and 2 to 3 weeks later collecting the secondary tumor growths and placing them into tissue culture. These tumor cells were then injected i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fidler IJ

    更新日期:1975-01-01 00:00:00

  • Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine.

    abstract::Mammalian DNA polymerase beta is a DNA repair enzyme expressed constitutively at a low level. In vitro, purified DNA polymerase (Pol) beta incorporates the nucleotide analogues 2'-3' deoxycytidine (ddC)-triphosphate and 3'-azido-3'-deoxythymidine (AZT)-triphosphate into DNA, causing chain termination. We have tested t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bouayadi K,Hoffmann JS,Fons P,Tiraby M,Reynes JP,Cazaux C

    更新日期:1997-01-01 00:00:00

  • Quantitative assessment of generalized epithelial changes in tracheal mucosa following exposure to 7,12-dimethylbenz(a)anthracene.

    abstract::Sequential morphological changes occurring after brief carcinogen exposures of heterotopic tracheal transplants in rats were semiquantitatively studied. Tracheas were exposed to 7,12-dimethylbenz(a)anthracene for 1, 2, or 4 weeks, during which time means of 138, 152, and 160 microgram 7,12-dimethylbenz(a)anthracene, r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Topping DC,Griesemer RA,Nettesheim P

    更新日期:1979-12-01 00:00:00

  • Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma.

    abstract::In the present study we have evaluated the prognostic significance of ploidy levels and proliferative activity in 279 cases of large bowel carcinomas which were included in a surgical prospective randomized trial. Ploidy levels and proliferative activity were determined on nuclei isolated from paraffin-embedded tissue...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schutte B,Reynders MM,Wiggers T,Arends JW,Volovics L,Bosman FT,Blijham GH

    更新日期:1987-10-15 00:00:00

  • Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

    abstract::Synovial sarcomas are aggressive spindle cell sarcomas containing in some cases areas of epithelial differentiation. They consistently show a specific t(X;18;p11;q11), which usually represents either of two gene fusions, SYT-SSX1 or SYT-SSX2, encoding putative transcriptional proteins differing at 13 amino acid positi...

    journal_title:Cancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Ladanyi M,Antonescu CR,Leung DH,Woodruff JM,Kawai A,Healey JH,Brennan MF,Bridge JA,Neff JR,Barr FG,Goldsmith JD,Brooks JS,Goldblum JR,Ali SZ,Shipley J,Cooper CS,Fisher C,Skytting B,Larsson O

    更新日期:2002-01-01 00:00:00

  • Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.

    abstract::The growth inhibitory effects of combinations of antifolates on hepatoma cells in culture have been examined. In these studies methotrexate or the lipophilic inhibitors of dihydrofolate reductase were used with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolate (PDDF). Under certain conditions partial ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Galivan J,Nimec Z,Rhee M

    更新日期:1987-10-15 00:00:00

  • Heterogeneity in the production of collagens and fibronectin by morphologically distinct clones of a human tumor cell line: evidence for intratumoral diversity in matrix protein biosynthesis.

    abstract::Recent studies of murine tumor models and certain human tumor cell lines have provided evidence for intratumor heterogeneity in expression of extracellular matrix receptors and in the elaboration of matrix-degrading enzymes. However, little is known about possible intratumoral heterogeneity in the production of matrix...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crouch EC,Stone KR,Bloch M,McDivitt RW

    更新日期:1987-11-15 00:00:00

  • IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide.

    abstract::Alkylating agents, such as temozolomide, are among the most effective cytotoxic agents used for malignant gliomas, but responses remain very poor. The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) plays an important role in cellular resistance to alkylating agents. IFN-beta can act as a drug sensiti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0036

    authors: Natsume A,Ishii D,Wakabayashi T,Tsuno T,Hatano H,Mizuno M,Yoshida J

    更新日期:2005-09-01 00:00:00

  • The diet, nutrition, and cancer program of the NCI National Cancer Program.

    abstract::In November 1974, in response to a mandate in the revised National Cancer Act of 1974, a plan was introduced for the formation of a Diet, Nutrition, and Cancer Program. Dr. Frank J. Rauscher, Director of the National Cancer Institute, selected a group of scientists who defined the goals of the program and recommended ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gori GB

    更新日期:1975-11-01 00:00:00

  • Antitumor effects of polyribonucleotides for mouse transitional cell carcinoma enhanced by cyclophosphamide.

    abstract::Mouse bladder tumor (MBT-2), derived from a carcinogen-induced transitional cell carcinoma of the bladder, has proven a useful model for study of pathogenesis and prediction of cytotoxic drug sensitivity of human bladder carcinoma. To define optimal conditions for activity of the potent interferon inducer polyriboinos...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Borden EC,Sidky YA,Groveman DS,Bryan GT

    更新日期:1985-01-01 00:00:00

  • Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability.

    abstract::Genetic instability has been recognized as a hallmark of human cancers. Retinoblastoma (Rb) tumor suppressor protein has an essential role in modulating cell cycle progression. However, there is no direct evidence supporting its role in maintaining genetic stability. Here, we developed a sensitive method to examine th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zheng L,Flesken-Nikitin A,Chen PL,Lee WH

    更新日期:2002-05-01 00:00:00

  • Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

    abstract::Brca2 is an important tumor suppressor associated with susceptibility to breast cancer. Although increasing evidence indicates that the primary function of Brca2 is to facilitate the repair of DNA damage via the homologous recombination pathway, how Brca2 prevents breast cancer is largely unknown. To study the role of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-2270

    authors: Cheung AM,Elia A,Tsao MS,Done S,Wagner KU,Hennighausen L,Hakem R,Mak TW

    更新日期:2004-03-15 00:00:00

  • Cellular interactions of CRKL, and SH2-SH3 adaptor protein.

    abstract::Chronic myelogenous leukemia is characterized by a specific chromosomal translocation, t(9;22), in which the ABL protooncogene and the BCR gene become juxtaposed. The chimeric BCR/ABL gene produces a P210 fusion protein with deregulated tyrosine kinase activity. We have recently isolated a complementary DNA, CRKL, whi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: ten Hoeve J,Kaartinen V,Fioretos T,Haataja L,Voncken JW,Heisterkamp N,Groffen J

    更新日期:1994-05-15 00:00:00

  • Intraocular tumor formation of RB reconstituted retinoblastoma cells.

    abstract::It has been reported that replacement of a functional retinoblastoma (RB) gene in RB defective WERI-27 retinoblastoma cells results in complete loss of their tumorigenic potential in nude mice following s.c. injection. We have repeated the identical studies and found that although tumors did not develop s.c., the RB r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Xu HJ,Sumegi J,Hu SX,Banerjee A,Uzvolgyi E,Klein G,Benedict WF

    更新日期:1991-08-15 00:00:00

  • DNA polymerase beta interacts with TRF2 and induces telomere dysfunction in a murine mammary cell line.

    abstract::DNA polymerase beta (Polbeta) is a DNA repair protein that functions in base excision repair and meiosis. The enzyme has deoxyribose phosphate lyase and polymerase activity, but it is error prone because it bears no proofreading activity. Errors in DNA repair can lead to the accumulation of mutations and consequently ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0136

    authors: Fotiadou P,Henegariu O,Sweasy JB

    更新日期:2004-06-01 00:00:00

  • Regulation of endogenous murine leukemia virus-related nuclear and cytoplasmic RNA complexity in C57BL/6J mice of increasing age.

    abstract::The nucleotide sequence complexity of murine leukemia virus *MuLV)-related RNA has been measured by RNA-complementary DNA hybridization analysis in nuclear and cytoplasmic RNA isolated from liver and brain of low-leukemia-strain C57BL/6J mice of different ages. In these two tissues, an approximate 1.5- to 2-fold incre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Florine DL,Ono T,Cutler RG,Getz MJ

    更新日期:1980-03-01 00:00:00

  • Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.

    abstract::The p53 mutant 143Ala is a human temperature-sensitive mutant with two conformational states. To definitively determine whether the Fas signal transduction pathway and the function of the pathway are dependent on p53 status, we have established stable transfectants of p53 mutant 143Ala in two human cancer cell lines: ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Li Y,Raffo AJ,Drew L,Mao Y,Tran A,Petrylak DP,Fine RL

    更新日期:2003-04-01 00:00:00

  • Serum acute-phase proteins and immunoglobulins in patients with gliomas.

    abstract::Cellular immune competence was found to be impaired in previous studies of patients with malignant brain tumors. In patients with nonneural tumors, we recently found that serum levels of acute-phase proteins were related to immune status as well as to tumor extent. To determine whether the serum proteins in patients w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weiss JF,Morantz RA,Bradley WP,Chretien PB

    更新日期:1979-02-01 00:00:00

  • The Inhibitor of Apoptosis Protein Livin Confers Resistance to Fas-Mediated Immune Cytotoxicity in Refractory Lymphoma.

    abstract::Death receptor Fas-mediated apoptosis not only eliminates nonspecific and autoreactive B cells but also plays a major role in antitumor immunity. However, the possible mechanisms underlying impairment of Fas-mediated induction of apoptosis during lymphomagenesis remain unknown. In this study, we employed our developed...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-3993

    authors: Sugihara E,Hashimoto N,Osuka S,Shimizu T,Ueno S,Okazaki S,Yaguchi T,Kawakami Y,Kosaki K,Sato TA,Okamoto S,Saya H

    更新日期:2020-10-15 00:00:00

  • Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver.

    abstract::The effects of chemical carcinogenesis to produce premalignant hyperplastic nodules in rat liver on concomitant immune function were studied. Induction of hyperplastic nodules in Fischer rats was accomplished using a combined regimen of diethylnitrosamine, 2-acetylaminofluorene, and partial hepatectomy. Hyperplastic n...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Leu RW,Norton TR,Herriott MJ,Ringer DP,Kearns RJ

    更新日期:1985-07-01 00:00:00

  • Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.

    abstract::Activated ras oncogene transfection into suitable recipient cells has been shown to induce the metastatic phenotype (Thorgeirsson, et al., Mol. Cell. Biol., 5: 259-262, 1985). We have used this model system to study the correlation of basement membrane collagenolysis with metastatic propensity. The c-Ha-ras oncogene a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Garbisa S,Pozzatti R,Muschel RJ,Saffiotti U,Ballin M,Goldfarb RH,Khoury G,Liotta LA

    更新日期:1987-03-15 00:00:00

  • Commentary on "Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents".

    abstract::The relatively recent clinical success of bortezomib, particularly in multiple myeloma, has established the validity of the proteasome as a viable target for anticancer drug development. This highly cited 1999 Cancer Research article from Adams and colleagues was published during the period when this drug was transiti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1974

    authors: Tew KD

    更新日期:2016-09-01 00:00:00